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Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) proteins
constitute an adaptive immune system in prokaryotes. The system preserves memories of prior infections by
integrating short segments of foreign DNA, termed spacers, into the CRISPR array in a process termed
adaptation. During the past 3 years, significant progress has beenmade on the genetic requirements andmo-
lecular mechanisms of adaptation. Here we review these recent advances, with a focus on the experimental
approaches that have been developed, the insights they generated, and a proposed mechanism for self-
versus non-self-discrimination during the process of spacer selection. We further describe the regulation
of adaptation and the protein players involved in this fascinating process that allows bacteria and archaea
to harbor adaptive immunity.Most archaea (90%) and many bacteria (50%) encode
CRISPR-Cas (clustered regularly interspaced short palindromic
repeats-CRISPR-associated) systems that confer adaptive
immunity against mobile genetic elements (MGEs) (Makarova
et al., 2015). The mechanisms involved in immunity rely on
small CRISPR RNAs (crRNAs) that guide Cas protein(s) to
cleave complementary foreign nucleic acids in a sequence-
specific manner (Barrangou et al., 2007; Brouns et al., 2008;
Garneau et al., 2010; Hale et al., 2009; Marraffini and Son-
theimer, 2008). The hallmark of CRISPR-Cas systems is the
CRISPR array, which consists of short repeated sequences (re-
peats) interspersed by unique sequence elements (spacers),
which frequently derive from MGEs such as plasmids and vi-
ruses (bacteriophages/phages) (Pourcel et al., 2005; Bolotin
et al., 2005; Mojica et al., 2005). The array is preceded by an
AT-rich leader containing a promoter. Transcription of the
CRISPR array generates precursor RNA molecules that are
further processed to generate the mature crRNAs. In this
context, spacer sequences provide the sequence specificity
for interference with invading nucleic acids.
The cas genes, located proximal to the CRISPR array, encode
the Cas proteins that play roles in the different stages of immu-
nity. According to a recently updated classification, CRISPR-
Cas systems can be grouped into class I and class II systems,
in which interference is carried out bymultiple proteins or a single
effector protein, respectively. On the basis of the presence of
signature proteins, these classes are further subdivided into
types I, III, and IV and types II, V, and VI systems, respectively
(Makarova et al., 2015). Following the invasion of a MGE, the
CRISPR-Cas system acts in three steps: (1) adaptation (or acqui-
sition), in which a new spacer derived from an invading sequence
is inserted into the CRISPR array; (2) crRNA biogenesis, in which
the CRISPR array is transcribed and the resulting precursorcrRNA is processed into mature crRNAs; and (3) interference,
in which the foreign nucleic acid is targeted and degraded by a
Cas-crRNA ribonucleoprotein complex (Marraffini, 2015).
Barrangou et al. (2007) were the first to demonstrate the adap-
tive nature of CRISPR-Cas immunity, confirming the earlier hy-
potheses that the CRISPR-Cas system conveys immunity
against MGEs (Makarova et al., 2006;Mojica et al., 2005; Pourcel
et al., 2005). Challenging the bacterium Streptococcus thermo-
philuswith phage resulted in the acquisition of phage-originating
spacers into the CRISPR array, which provided resistance to
matching phages upon further infection. The identification of
spacer uptake upon phage challenge proved to be an efficient
measure to analyze population dynamics, as several studies in
the Banfield lab demonstrated. Long-term co-culture experi-
ments combined with metagenomic approaches showed that
spacer uptake is a key factor that drives phage evolution
(Paez-Espino et al., 2015; Sun et al., 2015).
Two modes of adaptation have been reported for type I sys-
tems: (1) naive and (2) primed (Datsenko et al., 2012; Swarts
et al., 2012; Yosef et al., 2012). During naive adaptation, the or-
ganism obtains a spacer from a foreign DNA source. In contrast,
primed acquisition relies on a pre-existing (priming) spacer that
enables a biased and enhanced uptake of new spacers. Both
modes are based on the action of two key proteins, Cas1 and
Cas2. Naive adaptation requires only Cas1 and Cas2 (Yosef
et al., 2012), whereas primed adaptation additionally requires
the type I interference complex Cascade (CRISPR-associated
complex for antiviral defense) and the Cas3 nuclease (Datsenko
et al., 2012; Fineran et al., 2014; Swarts et al., 2012). Other
CRISPR-Cas types encode additional proteins that appear to
be involved in spacer acquisition. In the type I-A system of Ther-
moproteus tenax, a larger complex formed by Cas1, Cas2, Cas4,
and Csa1 was reported in vitro (Plagens et al., 2012). In vivoMolecular Cell 61, March 17, 2016 ª2016 Elsevier Inc. 797




Type Organism Naive/Primed Reference
1 I-A Sulfolobus solfataricus naive Erdmann and Garrett, 2012; Erdmann et al., 2014
Sulfolobus islandicus
1 I-B Haloarcula hispanica primed Li et al., 2014a, 2014b
1 I-E Escherichia coli naive + primed Datsenko et al., 2012; Dı´ez-Villasen˜or et al., 2013;
Fineran et al., 2014; Levy et al., 2015;
Savitskaya et al., 2013; Shmakov et al., 2014;
Swarts et al., 2012; Yosef et al., 2012, 2013
1 I-F Pectobacterium atrosepticum primed Richter et al., 2014
2 II-A Streptococcus thermophilus naive Barrangou et al., 2007; Deveau et al., 2008;
Garneau et al., 2010; Wei et al., 2015a;
Wei et al., 2015b
2 II-A Streptococcus agalactiae naive Lopez-Sanchez et al., 2012
2 II-A Streptococcus pyogenes Heler et al., 2015
1 III-B/I-A S. solfataricus naive Erdmann and Garrett, 2012; Erdmann et al., 2014
? S. islandicus
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strated direct involvement of Cas4 in adaptation (Li et al.,
2014b). In addition to Cas1 and Cas2, the two proteins Csn2
and Cas9 play essential roles for type II-A acquisition of
S. thermophilus and Streptococcus pyogenes (Heler et al.,
2015; Wei et al., 2015b).
For identifying a suitable protospacer for acquisition, type I
and type II systems use short 3–7 bp protospacer-adjacent mo-
tifs (PAMs) (Deveau et al., 2008; Garneau et al., 2010; Horvath
et al., 2008; Jinek et al., 2012; Mojica et al., 2009; Sapranauskas
et al., 2011). During naive adaptation in type II systems, Cas9
recognizes the PAM (Heler et al., 2015; Wei et al., 2015b),
whereas in type I-E systems, Cas1 and Cas2 are sufficient for
PAM recognition (Wang et al., 2015; Yosef et al., 2012). Following
protospacer selection and processing, the acquisition machin-
ery performs site-specific integration of the new spacer into
the CRISPR array at the leader end, concurrent with duplication
of the first repeat. Both the leader sequence and the first repeat
were shown to be essential, and studies of the Escherichia coli
type I-E and the S. thermophilus type II-A systems suggest
that the leader-repeat boundary serves as an anchor for spacer
integration (Wei et al., 2015a; Yosef et al., 2012).
In this review, we summarize recent advances in our under-
standing of adaptation in CRISPR-Cas immune systems. We
describe the experimental approaches that have been devel-
oped tomonitor spacer acquisition and discuss features of naive
and primed adaptation, self- versus non-self-discrimination, and
regulatory components for the adaptation process. Finally, we
highlight some future directions and remaining key questions.
Table 1 summarizes the model organisms discussed in the
review.
Methods for Studying Adaptation in CRISPR-Cas
Systems
Five years after the first demonstration of natural spacer acquisi-
tion in S. thermophilus, five assays were independently devel-
oped for the type I-E CRISPR-Cas system, establishing a basic798 Molecular Cell 61, March 17, 2016 ª2016 Elsevier Inc.framework for later studies, including a subsequent in vitro adap-
tation assay as described below.
To determine the DNA elements and proteins required for
adaptation, an assay was developed in which plasmid-encoded
Cas1 and Cas2 were co-expressed for 1–3 days in an E. coli
strain containing a CRISPR array but lacking cas genes (Yosef
et al., 2012). PCR amplification of a short segment between
the leader sequence and the existing spacers on the CRISPR
array was conducted using genomic DNA. Gel electrophoresis
analysis revealed two major bands: one band of a CRISPR array
amplified from DNA of the parental bacteria (no acquisition) and
a second band expanded by 61 bp in size, amplified fromDNA of
bacteria that did acquire a new spacer (Figure 1A). Sequences of
individual acquired spacers were subsequently analyzed. Reli-
able detection of adaptation could be achieved if at least 1%
of the bacteria acquired new spacers. In following studies, gel
extraction of the expanded band and high-throughput DNA
sequencing allowed the detection of less than 0.01% bacteria
that acquired spacers. This enabled the detection of spacer
acquisition at more physiological conditions, such as low Cas1
and Cas2 expression (Levy et al., 2015; Savitskaya et al., 2013;
Yosef et al., 2013). A modified PCR protocol using donor proto-
spacer-specific primers results in DNA amplification only when
the spacer of the corresponding donor protospacer is inserted
into the CRISPR array, enabling greater sensitivity and direct
comparison of adaptation efficiencies between different poten-
tial protospacer sequences (Figure 1B) (Yosef et al., 2013).
Another assay for monitoring spacer acquisition relies on pos-
itive selection of bacteria with expanded CRISPR arrays (Dı´ez-
Villasen˜or et al., 2013). By placing the CRISPR array upstream
of an out-of-frame antibiotic-resistance gene, spacer acquisition
and repeat duplication with subsequent restoration of the open
reading frame can be monitored via recovery of an antibiotic
resistance phenotype (Figure 1C). Because rare acquisition
events were positively selected, spacer acquisition was de-
tected even under conditions of low Cas1 and Cas2 expression
(Dı´ez-Villasen˜or et al., 2013).
Figure 1. Assays for Detecting Adaptation
(A) Bacteria with plasmid (green) driven expression
of Cas1 and Cas2 are grown for 1–3 days. PCR
amplification of the CRISPR array using genomic
DNA as template followed by gel electrophoresis
analysis reveals both parental and expanded
arrays.
(B) Same as in (A) but using a spacer-specific
primer to allow only amplification of expanded
arrays. A band on the gel is observed only when a
specific spacer was integrated.
(C) A plasmid-based CRISPR array leads to anti-
biotic resistance only upon spacer insertion and
repeat duplication.
(D) Donor spacer, acceptor plasmid, and Cas1 and
Cas2 are mixed in a test tube. Intermediates of
adaptation are observed by gel electrophoresis
analysis and further investigated by high-
throughput DNA sequencing.
(E) Bacteria harboring a plasmid are grown for
7–14 days. Adaptation is recorded by plasmid
curing. Antibiotic sensitive bacteria are then
selected for spacer acquisition analysis.
(F) Infection of bacteria by a phage results in low
naive acquisition, as detected by PCR analysis
(top). Acquisition primed by an existing spacer that
targets the invading DNA results in higher adap-
tation frequency (bottom).
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the establishment of an in vitro system that monitors spacer
acquisition intermediates in the E. coli type I-E system (Nun˜ez
et al., 2015b). In reactions with purified E. coli Cas1 and Cas2,
supercoiled plasmid DNA containing a CRISPR array and dou-
ble-stranded DNA (dsDNA) serving as a spacer donor, acquisi-
tion products were observed by agarose gel electrophoresis
and subjected to high-throughput DNA sequencing (Figure 1D).
Importantly, the system enabled testing different spacer donors,
which had not been possible with the in vivo studies (Nun˜ez et al.,
2015b). Nevertheless, the assay showed only intermediates of
adaptation, that is, half-site integration rather than fully inte-
grated spacers.
The above assays were used to detect naive adaptation. An
assay monitoring E. coli type I-E CRISPR-dependent plasmid
curing over time revealed the involvement of interference pro-
teins in primed adaptation (Swarts et al., 2012). Bacteria ex-
pressing the entire set of Cas proteins were propagated for
7–14 days. Plating the bacteria with or without antibiotic was
then used to monitor plasmid curing. Bacteria cured of the
plasmid were analyzed for spacer acquisition by sequencing
the amplified CRISPR array (Figure 1E). A modified assay moni-
tored spacer acquisition under similar conditions but with
bacterial strains that already contained a plasmid-targeting
spacer, thereby facilitating primed adaptation (Savitskaya
et al., 2013; Shmakov et al., 2014). This assay enabled high-
throughput monitoring of spacer acquisition after just a singleMolecular Cell 6overnight growth. Primed spacer acqui-
sition was also observed upon infection
by M13 phage when a phage-targeting
spacer already existed in the CRISPR
array (Datsenko et al., 2012) (Figure 1F).
Taken together, the above-describedassays are the major methods to monitor and characterize
adaptation.
Adaptation in Type I CRISPR-Cas Systems
Naive Adaptation
Using the PCR-based assay described above (Yosef et al.,
2012), it was shown that in the E. coli type I-E system, Cas1
and Cas2 are both necessary for spacer acquisition. The DNase
activity of Cas1 is required because a Cas1D221A nuclease-defi-
cient mutant (Babu et al., 2011) did not support spacer acquisi-
tion in vivo. The study determined that a single repeat is both
necessary and sufficient. By testing two variants of functional re-
peats followed by sequencing of the newly duplicated repeat, it
was shown that the inserted repeat is identical to the leader-
proximal repeat, indicating that this repeat is copied during
spacer adaptation (Yosef et al., 2012). These experiments further
demonstrated that the minimal required length of the leader is
40 to 60 bp upstream of the first repeat of the array, which was
later refined to be 40 to 43 bp (Dı´ez-Villasen˜or et al., 2013).
Protospacers with a flanking 50-AAG-30 PAM sequence were
selected as donors with 35% frequency, indicating that these
spacers are overrepresented compared with the PAM frequency
(1.6%). The absence of selection for functional spacers during
interference indicates that the acquisition machinery has an
intrinsic ability to recognize the correct PAM. Lower expression
of Cas1 and Cas2 resulted in more spacers having AAG PAMs
(U.Q., R. Sorek, A. Levy, and M.G. Goren, unpublished data).1, March 17, 2016 ª2016 Elsevier Inc. 799
Figure 2. Model for Spacer Integration into the CRISPR Array
Donor DNA (green, PAM in red) is inserted into a CRISPR array in a multi-step
process. The processing events that generate the mature donor DNAs are
unknown. Cas1 and Cas2 catalyze a nucleophilic attack of the 30-OH in an
orientation dictated by the last nucleotide of the PAM. The opposite 30-OH end
likely initiates another nucleophilic attack on the opposite strand of the array,
followed by gap filling.
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an unknown mechanism. The GC content of different proto-
spacers did not affect acquisition efficiency (Swarts et al.,
2012). However, an AA motif at the end of the spacer sequence
did increase adaptation efficiency, as determined by both low-
and high-throughput analyses (Fineran et al., 2014; Yosef
et al., 2013).
Mechanistically, the aforementioned in vitro assay using pu-
rified Cas1 and Cas2 proteins revealed that dsDNA rather than
single-stranded DNA (ssDNA) is the preferred substrate for
adaptation (Nun˜ez et al., 2015b). The 30-OH ends are essential
to make a nucleophilic attack on one strand of the repeat.
Cas1 and Cas2 integrate a spacer with the correct PAM orien-
tation by preferentially using the 30-OH C nucleotide that is
complementary to the G of the AAG PAM. These results, along
with intermediate adaptation products identified in vivo (Arslan
et al., 2014), suggest a model for naive adaptation in the E. coli
type I-E system (Figure 2). Because only reaction intermedi-
ates were monitored, some in vivo adaptation features were
not observed using the in vitro assay (Nun˜ez et al., 2015b).
Whereas the integration of new spacers occurs adjacent to
the leader-proximal repeat in vivo, spacer insertion was also
observed at other repeats and even outside the CRISPR
array in vitro. Furthermore, the length of new spacers varied800 Molecular Cell 61, March 17, 2016 ª2016 Elsevier Inc.substantially in vitro, while a strictly defined length of spacers
is observed in vivo. The in vitro system, however, reflects only
the final stages of spacer integration; that is, the donor DNA is
supplied in a ready-to-integrate form and prior processing
steps may specify spacer length and PAM preference (Yosef
and Qimron, 2015). Selection and processing of the spacer
donor from foreign DNA has yet to be demonstrated, and it
is not known how other proteins might hand-off spacer donors
to Cas1 and Cas2.
Interestingly, naive adaptation was not observed in two
studies of type I-B and I-F systems. Here, adaptation strictly
required priming (Li et al., 2014b; Richter et al., 2014). Given
that self-adaptation may pose a serious threat in constitutively
active systems, a prerequisite for priming may be reasonable.
In addition, it is possible that naive adaptation occurs in these
systems under conditions that have not yet been determined.
Primed Adaptation
Primed adaptation is characterized by an increased efficiency of
spacer acquisition in the presence of Cas1, Cas2, Cascade,
Cas3, and a ‘‘priming’’ spacer targeting an existing protospacer.
In the absence of any of these components, primed adaptation
does not occur (Datsenko et al., 2012). In type I-E system, prim-
ing enhances acquisition 10- to 20-fold over naive adaptation
(Datsenko et al., 2012; Savitskaya et al., 2013). The overall effi-
ciency of priming is significantly increased when the priming
spacer has mutations in the seed sequence or if the protospacer
has a non-cognate PAM (Datsenko et al., 2012). This suggests
that priming likely evolved as a mechanism to minimize infection
by phage escape mutants that would otherwise evade the inter-
ference machinery (Datsenko et al., 2012).
Primed adaptation in type I-E is biased to the strand orienta-
tion matching that of the protospacer targeted by the priming
spacer. In early experiments, it was shown that multiple rounds
of adaptation exclusively resulted in spacers acquired in the
same orientation of the first spacer (Swarts et al., 2012). This
observation was later validated in a controlled experiment in
which primed adaptation was monitored from two plasmids
harboring protospacers in either forward or reverse orientation.
Increased spacer acquisition in one strand of the plasmid
corroborated the orientation of the protospacer, indicating that
acquisition is facilitated from a primed strand (Datsenko et al.,
2012). This feature is not conserved in all type I systems, as
both type I-B and type I-F systems in contrast to the type I-E sys-
tem show primed adaptation in both strands (Li et al., 2014b;
Richter et al., 2014). In type I-F systems, the distribution of
acquired spacers exhibits a gradient centered at the targeted
protospacer (Figure 3). A clear gradient is not observed for
type I-B, yet less acquisition in distant regions compared with
the primed protospacer was observed.
Two major hypotheses have been proposed for the observed
strand selection. The first hypothesis suggests that degradation
products, generated by the interferencemachinery Cascade and
Cas3, are preferentially used as spacer donors. The degradation
fragments are produced in a defined orientation dictated by the
helicase directionality of Cas3 primarily on one strand (Sinkunas
et al., 2013; Swarts et al., 2012). This model, however, is difficult
to reconcile with the fact that a protospacer with seed or PAM
mutations, is less efficiently targeted by the interference
Figure 3. Primed Adaptation in Types I-E
and I-F
Adaptation is significantly enhanced by the pres-
ence of Cascade, Cas3, and a ‘‘priming’’ spacer
matching the target DNA. Arrows represent newly
acquired spacers. In type I-E, a gradient of spacers
was not detected, yet significantly preferred
acquisition from one strand was observed. In type
I-F, a gradient of spacers peaking near the priming
protospacer was observed on both strands.
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tion more efficiently. Another hypothesis suggests that DNA
‘‘sliding’’ by the interference proteins takes place following initial
binding to a protospacer (Datsenko et al., 2012). This hypothesis
assumes that sliding continues until an appropriate spacer adja-
cent to a cognate PAM is reached. Spacer acquisition in the re-
gion next to the targeted protospacer should be highest and
gradually decrease as a function of distance from that spacer.
Acquisition centered on the priming protospacer was indeed
observed in the type I-F system, supporting the sliding hypothe-
sis (Richter et al., 2014). However, both predictions of sliding
were not fulfilled in a high-throughput analysis of spacers ac-
quired from a plasmid in a type I-E system (Savitskaya et al.,
2013).
Recent biophysical studies of type I-E shed light on the mech-
anism of primed adaptation and, in particular, how the interfer-
ence machinery recruits the acquisition proteins. Early in vitro
studies showed that Cascade weakly binds to protospacers
containing mutated PAM or seed sequence (Semenova et al.,
2011; Westra et al., 2013b), suggesting that cells would select
against such sequences and/or that Cas3 recruitment would
fail. Recent single-molecule experiments demonstrated that
a non-canonical Cascade binding mode persists at mutated
protospacers and may be involved during primed adaptation
(Blosser et al., 2015). Even protospacers with a mutated PAM
can elicit highly stable Cascade binding (Szczelkun et al.,
2014). These studies, together with the identification of a specific
intermolecular Cascade-Cas3 interaction (Hochstrasser et al.,
2014), indicate that recognition of a consensus PAM by Cascade
is required for functional recruitment of Cas3 to promote an inter-
ference response (Hochstrasser et al., 2014), leaving open the
question how mutated PAMs and/or protospacers elicit priming
in a Cascade/Cas3-dependent process.Molecular Cell 6Real-time single-molecule fluores-
cence imaging was used to directly
visualize Cascade and Cas3 binding to
protospacers with either a consensus or
mutated PAM that elicits interference or
priming in vivo, respectively (Redding
et al., 2015). The results confirmed that
only consensus PAM binding promotes
Cas3 recruitment. Strikingly, the addition
of Cas1-Cas2 enabled Cascade to spe-
cifically recruit Cas3 to protospacers
with a mutated PAM. Moreover, with the
mutated PAM Cas3 could translocate in
both directions, unlike the unidirectionaltranslocation from the protospacer with consensus PAM. On
the basis of these data, it was proposed that Cas3 may travel
in complex with Cas1-Cas2, forming a larger spacer acquisition
complex. The 30/50 translocation behavior along both strands
could explain the strand bias of newly acquired spacers relative
to the priming protospacer (Datsenko et al., 2012; Li et al.,
2014b; Richter et al., 2014). Supporting experiments with a
type I-F system revealed a direct interaction between Cas1
and Cas3 (Richter et al., 2012). Early proteomics experiments
also revealed an interaction between Cas1 andmultiple subunits
of Cascade (Babu et al., 2011), providing a molecular basis by
which Cas1-Cas2 might assist in Cas3 recruitment. Recent
experiments have similarly provided evidence for direct interac-
tions betweenCas9 andCas1 in the type II-A system (Heler et al.,
2015), highlighting how interference and acquisition machineries
are linked in diverse CRISPR-Cas systems.
Regulation of Adaptation
Spacer adaptation can be a lethal process if self-spacers are ac-
quired. Regulators of CRISPR-Cas interference that act mostly
through transcription were identified in several systems. For
example, the E. coli type I-E system is regulated by the cyclic
AMP (cAMP) receptor protein (CRP) (Yang et al., 2014), his-
tone-like nucleoid-structuring protein (H-NS) (Pougach et al.,
2010; Pul et al., 2010), high-temperature protein G (Yosef
et al., 2011), and LeuO (Westra et al., 2010). However, few
studies have demonstrated regulation at the level of adaptation
activity of the systems.
In E. coli, it was shown that both naive and primed adaptation
occur in the absence of the negative regulator H-NS (Swarts
et al., 2012). H-NS represses the promoter of the operon that
comprises the genes encoding Cascade, cas1, and cas2, as
well as the transcription of the CRISPR array. Thus, H-NS de-
creases adaptation by its repressive effect on the promoter of1, March 17, 2016 ª2016 Elsevier Inc. 801
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tion system was recently identified in the Sulfolobus islandicus
type I-A system (Liu et al., 2015). Csa3a is encoded adjacent
to the cas operon and was shown to bind two promoters regu-
lating expression of the adaptation genes. Its overexpression re-
sulted in robust naive adaptation with low specificity for spacer
donors flanking cognate PAMs (67%–74%).
In the Pectobacterium atrosepticum type I-F system, the CRP
protein was shown to positively regulate the expression of the
entire cas operon by binding to a consensus motif located up-
stream of the cas1 gene (Patterson et al., 2015). Activation was
cAMP-dependent and required the AMP cyclase gene, cyaA.
Glucose and gene products such as GalM, which elevates the
concentration of the AMP cyclase, reduced the CRP-CyaA-
dependent cas operon transcription. Deletion of the CRP and
CyaA activators decreased primed adaptation, whereas deletion
of the galM gene increased primed adaptation. Interestingly, the
CRP regulator increases both adaptation and interference in
P. atrosepticum. It further increases cas gene transcription in
the Thermus thermophilus type I-E and type III-A systems yet re-
presses interference in the E. coli type I-E system. These
opposing regulatory roles may reflect the unique niches that
different bacteria occupy. The reverse roles played by this regu-
lator reveal that regulation of CRISPR-Cas systems, even within
a same subtype, is complex and not universal to all systems.
Despite these studies, it is still elusive whether adaptation is
driven by an invasive genetic element or by a general stress-
response-like phenomenon.
Adaptation in Type II CRISPR-Cas Systems
The first documented adaptation was shown in S. thermophilus
(Barrangou et al., 2007). New spacer sequences derived from in-
fecting lytic phages integrated into the CRISPR array. Resulting
bacteriophage-insensitive mutants were immune to repeated in-
fections. Using strains with a defective csn2 gene demonstrated
that this gene is required for efficient acquisition of new spacer
sequences.
Long-term co-culture experiments of S. thermophilus with
phage 2972 indicated that the uptake of chromosomal spacer
sequences resulting in autoimmunity is lethal for the cell as se-
lection against these sequences occurs (Paez-Espino et al.,
2013; Wei et al., 2015a). Spacer contents of type II-A CRISPR
arrays are shown to be highly diverse (Horvath et al., 2008;
Lopez-Sanchez et al., 2012), yet recent experiments show that
a bias toward certain spacer sequences of the phage genome
may reflect the effectiveness of an explicit spacer (Paez-Espino
et al., 2013), although in long-term experiments a selection
against ineffective or unfunctional spacer sequences occurs.
Using similar experimental setups as described above for
type I, Terns and co-workers set out to identify cis-acting ele-
ments involved in spacer acquisition in type II systems. Similar
to the findings of the E. coli type I-E system, the leader and a sin-
gle repeat are sufficient for efficient spacer uptake (Wei et al.,
2015a). Furthermore, 10 bp of the leader sequence at the
leader-repeat junction are essential for adaptation, and an iden-
tified ATTGA motif directly at the leader-repeat junction is highly
conserved among the CRISPR-Cas systems of different strepto-
cocci (Wei et al., 2015a). Similar sequence dependencies were802 Molecular Cell 61, March 17, 2016 ª2016 Elsevier Inc.observed for the leader proximal nucleotides of the repeat; intro-
duction of single- or double-nucleotide exchanges affected
adaptation, whereas repeat alterations at the leader distal part
had no effect. The leader proximal repeat nucleotides are essen-
tial for spacer acquisition but have no impact on crRNA biogen-
esis or interference (Wei et al., 2015a).
Remarkably, type II also requires Cas9 and trans-activating
crRNA as other essential elements during adaptation (Heler
et al., 2015; Wei et al., 2015b). Bacteria lacking Cas9 were un-
able to acquire new spacers, whereas Cas9 availability restored
spacer uptake during phage infection (Heler et al., 2015; Wei
et al., 2015b). Experiments using either Cas9 of S. pyogenes or
S. thermophilus demonstrated a functional interchangeability
of these proteins. The observed PAMs for newly acquired
spacers perfectly matched the PAM specificity of the respective
Cas9, leading to the hypothesis that Cas9 defines the PAM dur-
ing adaptation. To confirm this, catalytically inactive Cas9 and
variants with mutated PAM recognition residues were tested.
Remarkably, catalytically inactive Cas9 still enabled robust
spacer acquisition with the correct PAM, whereas new spacers
without defined PAM were acquired when the PAM-interacting
residues were mutated (Heler et al., 2015; Wei et al., 2015b).
Earlier studies in type I demonstrated that proteins involved in
adaptation form large multi-subunit complexes (Nun˜ez et al.,
2014; Plagens et al., 2012). Similarly, possible interactions be-
tween all four proteins required for adaptation (Cas9, Cas1,
Cas2 and Csn2) were indicated for type II-A (Heler et al., 2015).
In most cases, during a brief period of phage attack, the
CRISPR-Cas system must acquire a spacer from an invading
phage, generate mature crRNAs, assemble the interference
complex and target nucleic acids from the phage in order to pre-
vent lysis. Using defective phages to infect S. thermophilus, Hy-
nes et al. (2014) demonstrated that this treatment is similar to
classical vaccination. Phages damaged by UV light result in
defective phages that are less potent in killing the bacteria.
The frequency of spacer uptake was higher upon infections
with a defective phage compared with infections using wild-
type phage. The defective phage thus appears to ‘‘buy’’ time
and allow the CRISPR-Cas system to adapt and mount an im-
mune response.
Adaptation in Type III CRISPR-Cas Systems and Other
Pathways
Given the high diversity of CRIPSR-Cas subtypes, it is not sur-
prising that pathways other than the described naive and primed
adaptation exist. Studies of the CRISPR-Cas systems of Sulfolo-
bales identified a unique spacer acquisition pattern. The different
species of Sulfolobus that are under investigation in the Garrett
laboratory contain multiple systems of type I and type III. Garrett
and colleagues were able to observe spacer acquisition after
challenging S. solfataricus with a mixture of phages isolated
from Yellowstone National Park. Interestingly, the sequenced
spacers matched to open reading frames of a conjugative
plasmid, indicating that this spacer uptake was only observed
during co-infection with the conjugative plasmid (Erdmann and
Garrett, 2012). Analysis of the integration site revealed that
most of the spacers were integrated proximal to the leader as
was reported previously for type I (Yosef et al., 2012). A few
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spacers were inserted at different repeats of the array, with the
majority being integrated after the fourth repeat. Similar results
were obtained when S. islandicus was infected with a phage
mixture and spacers were acquired from only one of the two
phages (Erdmann et al., 2014). In the latter case, adaptation
was directly associated to a type I-A system. Many thermophilic
organisms tend to have more than one CRISPR array, and it is
often difficult to directly assign the arrays to a specific
CRISPR-Cas system. It is possible that acquisition events
observed inS. solfataricuswere actually adaptation events asso-
ciated with the activity of the type I-A system (Erdmann and Gar-
rett, 2012; Erdmann et al., 2014). In agreement, it was shown that
the type III-B system of S. solfataricus exploited the Cas6a
enzyme of the type I-A system to process the type III-B crRNAs
(Deng et al., 2013). The identification of PAMs for the newly ac-
quired spacers in S. solfataricus (Erdmann and Garrett, 2012)
can be seen as further evidence, because type III systems do
not use PAMs during target interference. Furthermore, type
III-B systems often lack an adaptation module (Erdmann et al.,
2013; Shah et al., 2013). Therefore, it is tempting to speculate
about a crosstalk among these types with respect to adaptation.
Interestingly, spacers were not acquired from the wild-type virus
that stimulated spacer acquisition from other foreign DNA sour-
ces. These observations highlight yet another possible adapta-
tion mechanism that should be further elucidated.
Self- versus Non-self-discrimination during Adaptation
Spacers represent potential targets for the interference machin-
ery, as they bear perfect complementarity to the crRNAs they
encode. In type III, the extended base pair complementarity of
crRNAs with the repeats in the array prevents autoimmunity
(Marraffini and Sontheimer, 2010). In type I and type II, targeting
during interference occurs through specific recognition of the
PAM adjacent to the protospacer (Sashital et al., 2011; Seme-
nova et al., 2011; Westra et al., 2013a). The absence of PAMs
in spacer-flanking sequences in the CRISPR array prevents
self-recognition. Consistent with early studies proposing that
PAM specificity occurs upon spacer selection (Mojica et al.,
2009), naive adaptation assays have revealed that the acquisi-
tion machinery also has an intrinsic PAM specificity (Yosef
et al., 2012, 2013). Independent recognition of the PAM during
both adaptation and interference may increase the ability to pre-
vent a lethal autoimmune response. This redundancymay further
explain the enhanced specificity of spacer acquisition with
consensus PAM during primed over naive adaptation (Savit-
skaya et al., 2013). PAM specificity during adaptation and inter-
ference of type I are overlapping but non-identical (Fineran et al.,
2014; Yosef et al., 2012).
Mutations in the PAM or seed sequence of a protospacer (De-
veau et al., 2008; Fineran et al., 2014; Semenova et al., 2011)
substantially reduce the binding affinity of Cascade (Semenova
et al., 2011; Westra et al., 2013a) and perturb the recruitment
and/or cleavage activity of the Cas3 nuclease (Hochstrasser
et al., 2014; Rutkauskas et al., 2015) in type I-E systems leading
to evasion of interference. A high-throughput study examining
sequence determinants of interference and priming demon-
strated that up to 13 mutations within the protospacer and atleast 22 mutated PAMs still elicit a priming response in type I-E
(Fineran et al., 2014). Similarly, up to 19 mutated PAMs elicited
priming for type I-B, as well as the 4 consensus PAMs that func-
tion for interference (Li et al., 2014a), highlighting the plasticity
with which the interference machinery can adapt to escape
phage. In the latter study, priming was abrogated when the
mutated PAM matched the 30 end of the spacer flanking repeat
sequence, explaining how self-priming is specifically avoided.
Naive adaptation experiments demonstrated that Cas1 and
Cas2 of type I-E prefer spacers from plasmids rather than the
chromosome, despite the large excess of chromosomal DNA
(Yosef et al., 2012). The chromosomal DNA content was
25–50 times greater than the plasmid DNA content. Yet chro-
mosome-derived spacers represented only 2%–22% of the
total spacers acquired, depending onCas1 andCas2 expression
levels. This represents a 100- to 1,000-fold preference in spacer
acquisition from plasmid over the chromosome. The observed
ratio seems due to inherent preference for foreign DNA in the
adaptation process, rather than selective pressure against chro-
mosomal spacer acquisition. In contrast, such preference was
not observed for naive adaptation in the type II-A system of
S. thermophilus, indicating that protection from self-immunity
may operate via a different pathway (Wei et al., 2015b).
A recent model proposes that two main mechanisms account
for this preference (Levy et al., 2015). One mechanism was deci-
phered after discovering that the recombination/repair complex
RecBCD facilitates adaptation. RecBCD is known to interact
with an octamer sequence called Crossover Hotspot Instigator
(Chi) (Smith, 2012). It was shown that acquisition is significantly
higher from protospacers located immediately upstream of a
Chi site, suggesting that Cas1 and Cas2 may depend on
RecBCD for spacer acquisition and that Chi sites may attenuate
their activity (Levy et al., 2015). The observation that the E. coli
chromosome contains a 15-fold overrepresentation of Chi
sites compared with plasmids suggests a mechanism for spe-
cific avoidance of self-DNA. In fact, spacer acquisition was spe-
cifically reduced from a plasmid containing additional Chi sites
(Levy et al., 2015) (Figure 4). The second mechanism explaining
foreign DNA preference was revealed when spacer acquisition
hot spots were found upstream of replication stalling sites called
Ter sites (Levy et al., 2015). During bidirectional DNA replication,
Ter sites stall the faster moving replication fork until the slower
replication fork completes replication, allowing for chromosome
decatenation (Neylon et al., 2005). DNA nicks and double-strand
breaks, which also stall the replication fork, exhibited additional
hot spots. These findings suggested that spacer acquisition is
highest from DNA regions undergoing frequent replication stalls.
The high copy number of plasmids consequently means a
greater occurrence of termination events, compared with chro-
mosomal DNA replication, which terminates only once in each
growth cycle. Thus, the acquisition machinery should exhibit a
natural preference for any high-copy DNA (Figure 4).
Structural Insights into Adaptation
The nuclease/integrase function of Cas1 was predicted in 2006
(Makarova et al., 2006), and the adjacency of the cas1 and
cas2 genes in most cas operons led to the hypothesis of func-
tional cooperation between both proteins in spacer acquisitionMolecular Cell 61, March 17, 2016 ª2016 Elsevier Inc. 803
Figure 4. A Model for Self- and Non-self-
discrimination in Type I-E
(A) In a RecBCD-dependent mechanism, Chi sites
reduce the amount of sequences available for
spacer donor selection.
(B) Major hot spots for adaptation are replication-
stall sites, such as replication termination (lightning
symbol). High-copy elements have more replica-
tion-stall sites than the chromosome, leading to
more frequent acquisition of spacers from these
elements.
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have attempted to make inroads into the mechanism of adapta-
tion through structural studies of Cas1 (30 kDa) and Cas2
(10 kDa).
Cas1 proteins from six different bacteria and one phage have
been crystallized (Babu et al., 2011; Kim et al., 2013; Wiedenheft
et al., 2009). Cas1 adopts a novel fold that can be divided into an
N-terminal domain comprising primarily b strands and a C-termi-
nal a-helical domain (Figure 5A). Interactions between the N-ter-
minal domains from adjacent protomers promote stable Cas1
dimerization, and the C-terminal domain contains three highly
conserved residues (E141, H208, and D221; E. coli numbering)
that coordinate a divalent metal ion and form the putative active
site (Wiedenheft et al., 2009). Studies of Cas1 from Pseudo-
monas aeruginosa, E. coli, and Archaeoglobus fulgidus demon-
strated that mutating any of these residues largely eliminated
the observed nuclease activity. However, the structures failed
to provide significant insights into substrate specificity, and
nuclease activity was observed against a range of different sub-
strates, including single-stranded RNA (ssRNA), ssDNA, dsDNA,
branched DNA, and plasmid DNA structures (Babu et al., 2011;
Kim et al., 2013; Wiedenheft et al., 2009).
Studies of Cas2 similarly show various enzyme activities. An
early study detected nuclease activity on ssRNA substrates
but not DNA for six different Cas2 homologs (Beloglazova
et al., 2008), whereas subsequent studies observed either no
nuclease activity (Samai et al., 2010) or degradation of dsDNA
(Ka et al., 2014; Nam et al., 2012). Regardless of whether these
differences are artifacts or result from the evolutionary distance
separating the tested homologs, Cas2 crystal structures pre-
sented in these studies reveal a highly conserved 3D architec-
ture. Cas2 is a small, single-domain protein that exhibits the804 Molecular Cell 61, March 17, 2016 ª2016 Elsevier Inc.ferredoxin-like fold also found in Cas5
and Cas6 proteins (Li, 2015), and like
Cas1, Cas2 forms a stable homodimer
(Figure 5A).
A breakthrough in the structural under-
standing of spacer acquisition was the
finding that Cas1 and Cas2 assemble
into a larger complex and that complex
formation facilitates in vitro spacer inte-
gration and CRISPR DNA binding and is
critical for adaptation in vivo (Nun˜ez
et al., 2014, 2015b). The crystal structure
of Cas1-Cas2 from E. coli (Nun˜ez et al.,
2014) reveals a heterohexameric, crab-like architecture with pseudo-two-fold symmetry, in which a cen-
tral Cas2 dimer interacts on two opposite faces with separate
Cas1 dimers (Figure 5A). The Cas1-Cas2 interface is stabilized
by a combination of electrostatic and hydrophobic interactions.
Impairment of this interface perturbs complex formation in vitro,
as well as spacer acquisition in vivo. Although purified Cas1-
Cas2 showed non-specific DNA binding, perhaps reflecting the
flexibility of spacer donor sequences, overexpressed Cas1-
Cas2 in cell lysate specifically bound DNA containing a CRISPR
array and leader sequence. This suggests that yet unidentified
accessory factors may facilitate loading of Cas1-Cas2 onto the
CRISPR array for efficient integration. Furthermore, specific
CRISPR DNA binding by Cas1 was dependent on the presence
of Cas2, suggesting that the primary role of Cas2may be confor-
mational and involves restructuring of Cas1. In agreement with
this hypothesis, spacer acquisition in vivo was completely unaf-
fected by Cas2 active-site mutations but abolished by Cas1
active-site mutations.
Two recently reported crystal structures of the E. coli Cas1-
Cas2 complex bound to spacer donor DNA substrates shed
light on the mechanisms of foreign DNA capture, PAM recogni-
tion and CRISPR integration (Nun˜ez et al., 2015a; Wang et al.,
2015). The Cas1-Cas2 complex binds a splayed, dual-fork
DNA substrate in which 23 bp of dsDNA are flanked by 30 sin-
gle-stranded overhangs that are threaded into two symmetry-
related Cas1 active sites (Figure 5B). Tyrosine residues from
the sameCas1monomers (Y22) bracket the double-stranded re-
gion via stacking interactions, explaining howCas1-Cas2 acts as
a caliper to accurately measure the length of new spacers. These
residues may act like a wedge to generate double-strand/single-
strand junctions. Wang et al. (2015) succeeded in crystallizing
Cas1-Cas2 with a spacer donor containing the PAM, revealing
Figure 5. Structure of the Type I-E
Acquisition Complex
(A) Crystal structure of E. coli Cas1-Cas2 complex
(PDB: 4P6I) (Nun˜ez et al., 2014). A Cas2 dimer
(light and dark green) is sandwiched by two Cas1
dimers (light blue and gray), forming a 150 kDa
heterohexameric complex.
(B) Crystal structure of the E. coli Cas1-Cas2
complex bound to PAM-containing DNA (PDB:
5DQZ) (Wang et al., 2015), colored as in (A). The
DNA contains 23 bp of dsDNA flanked by ssDNA
overhangs. The inset (right) shows how the PAM-
complementary 50-CTT-30 sequence is specifically
recognized, positioning the scissile phosphate in
the active site.
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(Figure 5). Cas1 specifically recognizes the PAM-complemen-
tary 50-CTT-30 sequence within the 30 single-stranded overhang
region. This helps position the phosphodiester bond following
the C nucleotide within the Cas1 active site, that spacer donor
precursors can be trimmed down to the correct length
(Figure 5B). Finally, using data from alternative crystal forms,
Nun˜ez et al. (2015a) proposed an intriguing structural model
that explains how Cas1-Cas2 may position spacer donor and
acceptor CRISPR DNA to promote the integration reaction.
Conclusions and Future Directions
Numerous studies have been published on the interference ac-
tivity of CRISPR-Cas immune systems, and only a few dozen
studies have been published on the adaptation step. It remains
the least understood pathway in CRISPR-Cas immunity. Below,
we list several key issues that in our opinion must be resolved for
a deeper understanding of the adaptation process.
Spacer Biogenesis
How foreign DNA is processed into the spacer donor that is
further integrated into the CRISPR array is a question that
requires thorough examination. For example, it is unclear how
spacer donors are excised and loaded onto the Cas1-Cas2
complex. Other questions involve the precise roles of RecBCD
and Cas3 during naive and primed adaptation in type I-E
systems.
Leader Recognition
New spacers are mostly integrated at the leader-repeat bound-
ary of CRISPR arrays (Yosef et al., 2012). However, it was shown
in vitro that spacers can be inserted at sites even outside the
CRISPR array (Nun˜ez et al., 2015b). It is possible that the recog-Molecular Cell 6nition of the leader-proximal repeat
sequence requires additional proteins
other than Cas1 and Cas2.
Mechanism of Primed Adaptation
The priming mechanism is still elusive.
A gradient of spacers centered near the
primed protospacer was observed in
one experimental setup (Richter et al.,
2014). Thus, sliding from the primed
site is a reasonable mechanism for
primed adaptation. The components of
this sliding complex could be Cascade,Cas3, Cas1, and Cas2 or a complex of Cas1, Cas2, and Cas3.
In the latter case, the main role of Cascade may be to mediate
interactions between the Cas1-Cas2 complex and Cas3. The
interplay between these proteins is a major question to be
elucidated.
More Studies Required for Type III Adaptation
Knowledge about spacer acquisition in type III systems is
sparse. The typical lack of Cas1 and Cas2 in type III-B and the
co-occurrence of type III systems together with another type I
or type II system highlight the potential of crosstalks among
these systems. It is noteworthy that the vast amount of these
systems exists in bacteria and archaea that are not easy to
manipulate or for which the access to phages is limited. Heterol-
ogous expression systems are more experimentally tractable
and could help to overcome these drawbacks.
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